Live Breaking News & Updates on Subject expert committee

Stay informed with the latest breaking news from Subject expert committee on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Subject expert committee and stay connected to the pulse of your community

Entod Pharma receives regulatory approval for Presbyopia eye drops

Entod Pharma receives regulatory approval for Presbyopia eye drops
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

India , Entod-pharmaceuticals , Central-drugs-standard-control-organisation , Expert-committee , Subject-expert-committee ,

Coronavirus updates | India records 42,618 Covid cases, 330 deaths in a day

With 42,618 people testing positive for coronavirus, India's total tally of COVID-19 cases rose to 3,29,45,907, while active cases touched 4,05,681. The death toll climbed to 4,40,225 with 330 fresh fatalities, according to the data updated at 8 a.m.In a span of 24 hours, the active caseload rose by 5,903. The number of active cases now comprise 1.23% of the total infections, while the

India , New-zealand , Nepal , Oman , China , Pakistan , Villianur , Pondicherry , United-arab-emirates , Hawaii , United-states , Karnataka

National News: Subject Expert Committee to meet on Dec 10 to discuss approval for Covishield booster dose | India News – Rashtra News

Subject Expert Committee to meet on Dec 10 to discuss approval for Covishield booster dose | India News - Rashtra News : Rashtra News #Subject #Expert #Committee #meet #Dec #discuss #approval #Covishield #booster #dose #India #News #Times #India NEW DELHI: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold

India , Serum-institute-of-india , Serum-institute , National-technical-advisory-group-on-immunisation , Central-drugs-standard-control-organization , Expert-committee , Subject-expert-committee , India-news , Rashtra-news , Drugs-controller-general , National-technical-advisory-group

Why pharma majors are rushing to put anti-obesity drugs on Indian shelves

As the market for anti-obesity drugs in India grows rapidly, pharma majors like Dr. Reddy's, Zydus, and Sun Pharma are competing to quickly enter the market with weight-loss drugs - Issue Date: Jan 07, 2024

Switzerland , Delhi , India , Denmark , Anoop-misra , Eli-lilly-mounjaro , Pradeep-chowbey , Novo-nordisk , Sukhvinder-singh-saggu , Sheetal-sapale , Max-chowbey , Eli-lilly

Drug regulator warns, bans use of cold, flu cough syrups

New Delhi: The Drugs general controller (India) wrote a letter on December 18, to all states and asked states and Union Territories to update the package

India , New-delhi , Delhi , Expert-committee-pulmonary , Union-territories , Chlorpheniramine-maleate , Subject-expert-committee , Sir-gangaram-hospital , Promotional-literature , Cough-syrups , Lu

Govt bans anti-cold drug combination for kids aged under four

The latest directive requires manufacturers to label their products with the warning that the "FDC (fixed-drug combination) should not be used in children below 4 years of age"

India , Gambia , Cameroon , Uzbekistan , World-health-organization , Expert-committee-pulmonary , Central-drugs-standard-control-organisation , Subject-expert-committee , Nti-cold-drug-combination ,

Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years

Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
sahilonline.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sahilonline.org Daily Mail and Mail on Sunday newspapers.

New-delhi , Delhi , India , Rajeev-raghuvanshi , Professor-kokate-committee , Expert-committee-pulmonary , Central-drugs-standard-control-organisation , Controller-general , Chlorpheniramine-maleate , Subject-expert-committee ,

Govt Bans Anti-cold Fixed Drug Combination for Children Below 4 Years in Age

Govt Bans Anti-cold Fixed Drug Combination for Children Below 4 Years in Age
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

India , Rajeev-raghuvanshi , Expert-committee-pulmonary , Professor-kokate-committee , Central-drugs-standard-control-organisation , Controller-general , Chlorpheniramine-maleate , Subject-expert-committee ,

Govt Bans These Cold & Flu Syrups for Infants, Kids Below 4; Pharma Firms to Insert Warning | See List

While the combination, called fixed-dose combination, was already under scanner for being “irrational”, the government committee had approved it after finding reasonable evidence

United-states , India , Delhi , Rajeev-singh-raghuvanshi , European-union , Central-drugs-standard-control-organisation , Union-territories , Expert-committee-pulmonary , T-minic-oral-drops , Ascoril-flu-syrup , Solvin-cold-syrup , Use-among

Drug regulator issues warning against cold medication for children under 4 yrs

The the Subject Expert Committee of the Central Drugs Standard Control Organisation recommended a precautionary measure, suggesting that the FDC should not be administered to children below 4 years

Drug-administration , Central-drugs-standard-control-organisation , Professor-kokate-committee , Nonprescription-drugs-advisory-committee , During-the-subject-expert-committee-pulmonary , Fixed-dose-combination , Chlorpheniramine-maleate , Subject-expert-committee , Professor-kokate , Cough-syrup , Ndia